StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2023 - 05 - 15
1
2022 - 10 - 31
1
2022 - 09 - 07
1
2022 - 06 - 03
1
2022 - 02 - 07
1
2021 - 12 - 13
1
2021 - 12 - 03
1
2021 - 10 - 14
1
2021 - 09 - 30
1
2021 - 05 - 19
1
2021 - 03 - 18
1
Sector
Electronic technology
1
Health technology
11
Tags
Active
1
Approval
1
Australia
1
Breast cancer
1
Cancer
1
Car-t
1
China
2
Clearance
1
Clinical-trials-phase-iii
1
Commercialization
1
Dermatitis
1
Diabetes
1
Drug
1
Expected
1
Fda
1
Genomics
1
Group
1
Growing
1
Growth
1
Hiv
1
Hypertension
1
Ibi343
1
Infections
1
Insulin
1
Iot
1
Life science
1
Lipodystrophy
1
Ly3471
1
Market
1
N/a
8
News
2
Pharma
1
Phase 3
1
Presentation
1
Profitable
1
Psoriasis
1
Report
1
Research
1
Results
1
Service
1
Services
1
Study
1
System
1
Therapeutics
2
Therapy
1
Treatment
1
Trial
1
Tumors
1
Virus
1
Entities
Abb ltd
32
Abbott laboratories
20
Abbvie inc.
20
Accenture plc
26
Addex therapeutics ltd
36
Adobe inc.
15
Alphabet inc.
37
Alstom
22
Apple inc.
25
Arcelormittal
15
Argenx se
29
Arrival
97
Astellas pharma inc
14
Astrazeneca plc
13
Blackrock, inc.
16
Bnp paribas
270
Borr drilling limited
14
Broadcom inc.
15
Caledonia mining corporation plc
23
Celyad sa
17
Cummins inc.
15
Dell technologies inc.
13
Denso corp
13
Dow inc.
15
Equinor asa
73
Ericsson
43
Flex lng ltd.
35
Gam holding ag
16
Honeywell international inc.
42
Idex biometrics asa - adr
18
Indivior plc
13
Infineon technologies ag
14
Innate pharma s.a.
27
Johnson & johnson
81
Johnson controls international plc
21
Kbc group nv
18
Kering
15
Koninklijke philips n.v.
15
Medtronic plc
20
Morgan stanley
40
Nec corp
14
Novartis ag
69
Novo nordisk a/s
33
Obseva sa
25
Oncocyte corporation
16
Ooma, inc.
27
Orange
96
Regeneron pharmaceuticals, inc.
27
Sanofi
156
Sap se
44
Sealsq corp
30
Sohu.com limited
14
Stellantis n.v
16
Teck resources ltd
15
Teekay corporation
14
Teva pharmaceutical industries ltd
16
Thermo fisher scientific inc
24
Veon ltd.
29
Verona pharma plc
18
Wisekey international holding ag
67
Symbols
ABCM
1
AZN
1
AZNCF
1
BGNE
1
BMY
1
GLAXF
1
GSK
1
HCM
1
INCY
2
LLY
11
MESO
1
NBIX
1
NKTR
1
NVDA
1
NVS
1
NVSEF
1
PFE
1
SNY
3
SNYNF
3
Exchanges
Nasdaq
7
Nyse
11
Crawled Date
2023 - 05 - 15
1
2022 - 10 - 31
1
2022 - 09 - 07
1
2022 - 06 - 03
1
2022 - 02 - 07
1
2021 - 12 - 13
1
2021 - 12 - 03
1
2021 - 10 - 14
1
2021 - 09 - 30
1
2021 - 05 - 19
1
2021 - 03 - 18
1
Crawled Time
00:00
74
00:01
1
00:20
9
01:00
112
01:15
1
02:00
23
02:11
1
03:00
13
04:00
5
04:20
9
05:00
14
06:00
11
07:00
13
08:00
22
09:00
19
10:00
31
10:51
1
11:00
111
11:36
1
12:00
173
12:03
2
12:07
5
12:09
2
12:10
1
12:11
7
12:15
19
12:20
29
12:30
19
12:34
1
12:39
1
12:40
1
13:00
100
13:01
1
13:07
1
13:15
8
13:20
25
13:30
11
14:00
77
14:15
8
14:20
11
14:30
18
15:00
84
15:15
3
15:20
22
15:30
19
16:00
95
16:20
11
17:00
67
18:00
60
18:17
2
18:31
2
19:00
53
19:11
2
20:00
46
20:20
3
21:00
94
22:00
70
22:04
2
23:00
52
23:07
2
Source
www.biospace.com
3
www.globenewswire.com
5
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Eli lilly and company
crawled time :
06:00
save search
New Sandoz Board of Directors appointed
Published:
2023-05-15
(Crawled : 06:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
10.61%
|
O:
-1.1%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.15%
|
O:
0.2%
H:
0.13%
C:
-0.22%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
70.12%
|
O:
0.22%
H:
0.14%
C:
-0.2%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-13.0%
|
O:
0.38%
H:
0.0%
C:
0.0%
NVDA
|
News
|
$796.78
-3.33%
-4.92%
50M
|
Electronic Technology
|
190.84%
|
O:
0.59%
H:
1.62%
C:
1.56%
Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 (Recombinant anti-Claudin18.2 Monoclonal Antibody-drug Conjugate) in Patients with Advanced Solid Tumors Innovent Biologi...
Published:
2022-10-31
(Crawled : 06:00)
- biospace.com/
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
11.16%
|
O:
2.76%
H:
0.0%
C:
-5.14%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
105.35%
|
O:
-0.35%
H:
1.47%
C:
0.96%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
9.81%
|
O:
0.57%
H:
0.0%
C:
0.0%
MESO
|
$6.21
3.5%
3.38%
200K
|
Health Technology
|
-74.05%
|
O:
1.04%
H:
0.0%
C:
-0.34%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-30.76%
|
O:
-0.84%
H:
1.0%
C:
0.5%
ibi343
australia
tumors
study
Nektar Therapeutics Presents Data for Rezpegaldesleukin (LY3471851) in Patients with Atopic Dermatitis and Psoriasis from Two Separate Clinical Studies at 2022 European Academy of Dermatology (EADV) Congress
Published:
2022-09-07
(Crawled : 06:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
140.87%
|
O:
0.64%
H:
1.18%
C:
0.92%
NKTR
|
News
|
$1.39
-2.11%
-2.16%
960K
|
Health Technology
|
-63.16%
|
O:
-1.86%
H:
5.15%
C:
2.98%
ly3471
dermatitis
therapeutics
psoriasis
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published:
2022-06-03
(Crawled : 06:00)
- biospace.com/
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-26.78%
|
O:
-1.55%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-11.71%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
9.0%
|
O:
-0.4%
H:
4.05%
C:
-1.35%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-49.67%
|
O:
0.57%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-4.6%
|
O:
-0.14%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
138.4%
|
O:
-2.25%
H:
0.0%
C:
0.0%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-35.09%
|
O:
-1.4%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.28%
|
O:
-0.09%
H:
0.0%
C:
0.0%
NBIX
|
News
M
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
52.15%
|
O:
2.29%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
6.56%
|
O:
-0.56%
H:
0.82%
C:
-0.64%
lipodystrophy
treatment
research
system
active
services
report
service
growing
hiv
profitable
hypertension
genomics
expected
virus
approval
cancer
growth
group
market
breast cancer
infections
FDA Action Alert: Innovent, Pfizer-BioNtech and Agios
Published:
2022-02-07
(Crawled : 06:00)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
205.83%
|
O:
0.55%
H:
0.0%
C:
0.0%
fda
IASO Biotherapeutics and Innovent Biologics Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting
Published:
2021-12-13
(Crawled : 06:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
204.6%
|
O:
1.27%
H:
0.0%
C:
0.0%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-22.33%
|
O:
-2.44%
H:
0.0%
C:
0.0%
car-t
therapeutics
presentation
therapy
iot
HUTCHMED Announces Agreement with NHSA for Continued Inclusion of ELUNATE® and Addition of SULANDA® in the National Reimbursement Drug List in China
Published:
2021-12-03
(Crawled : 06:00)
- globenewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
199.74%
|
O:
2.15%
H:
0.0%
C:
0.0%
HCM
|
$18.405
0.85%
0.84%
58K
|
Health Technology
|
-47.02%
|
O:
-5.2%
H:
0.0%
C:
0.0%
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-60.78%
|
O:
-0.98%
H:
0.0%
C:
0.0%
drug
china
Adocia’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China
Published:
2021-10-14
(Crawled : 06:00)
- globenewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
212.57%
|
O:
0.24%
H:
0.6%
C:
-0.14%
diabetes
china
insulin
phase 3
trial
clearance
Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption
Published:
2021-09-30
(Crawled : 06:00)
- globenewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
220.82%
|
O:
1.05%
H:
1.88%
C:
-0.74%
results
Acacia Pharma Appoints Debra Hussain as Chief Commercial Officer
Published:
2021-05-19
(Crawled : 06:00)
- globenewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
279.72%
|
O:
-0.52%
H:
1.95%
C:
1.5%
commercialization
pharma
Microba Life Sciences appoints experienced executive Mark Capone to the Board
Published:
2021-03-18
(Crawled : 06:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
295.79%
|
O:
-0.38%
H:
0.58%
C:
-1.12%
ABCM
|
News
|
$23.99
0.0%
7.4M
|
Health Technology
|
12.95%
|
O:
-2.21%
H:
1.69%
C:
-1.16%
life science
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.